LogicBio Therapeutics, Inc. Financing Cash Flow
LogicBio Therapeutics, Inc. reported Financing Cash Flow of -$2.50 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-11-14
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was -$833.00K, a 138.51% decline year-over-year.
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was -$834.00K.
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was -$833.00K, a 139.84% decline year-over-year.
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was -$834.00K, a 101.84% decline year-over-year.
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $3.24M, a 93.35% decline from fiscal 2020.
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $48.72M, a 383.89% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $10.07M, a 86.07% decline from fiscal 2018.
- LogicBio Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2018 was $72.31M, a 151.91% increase from fiscal 2017.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$833.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.67M derived: sum of 2 quarters · filed 2022-11-14 | -$2.50M 10-Q · filed 2022-11-14 | -$3.33M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | -$834.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.67M 10-Q · filed 2022-08-15 | -$2.50M derived: sum of 3 quarters · filed 2022-08-15 | -$338.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | -$833.00K 10-Q · filed 2022-05-16 | -$1.67M derived: sum of 2 quarters · filed 2022-05-16 | $496.00K derived: sum of 3 quarters · filed 2022-11-14 | $316.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | -$834.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $1.33M derived: sum of 2 quarters · filed 2022-11-14 | $1.15M derived: sum of 3 quarters · filed 2022-11-14 | $3.24M 10-K · filed 2022-03-04 |
| 2021-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.98M derived: sum of 2 quarters · filed 2022-11-14 | $4.07M 10-Q · filed 2022-11-14 | $49.49M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.91M 10-Q · filed 2022-08-15 | $47.32M derived: sum of 3 quarters · filed 2022-08-15 | $48.64M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $2.09M 10-Q · filed 2022-05-16 | $47.50M derived: sum of 2 quarters · filed 2022-05-16 | $48.82M derived: sum of 3 quarters · filed 2022-05-16 | $50.73M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $45.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $46.73M derived: sum of 2 quarters · filed 2022-03-04 | $48.64M derived: sum of 3 quarters · filed 2022-03-04 | $48.72M 10-K · filed 2022-03-04 |
| 2020-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.23M derived: sum of 2 quarters · filed 2021-11-15 | $3.31M 10-Q · filed 2021-11-15 | $3.39M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.99M 10-Q · filed 2021-08-09 | $2.07M derived: sum of 3 quarters · filed 2021-08-09 | $11.98M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $84.00K 10-Q · filed 2021-05-10 | $165.00K derived: sum of 2 quarters · filed 2021-05-10 | $10.07M derived: sum of 3 quarters · filed 2021-05-10 | $10.15M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $9.99M derived: sum of 2 quarters · filed 2021-03-15 | $10.07M derived: sum of 3 quarters · filed 2021-03-15 | $10.07M 10-K · filed 2021-03-15 |
| 2019-09-30 | $9.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $9.99M derived: sum of 2 quarters · filed 2020-11-09 | $9.99M 10-Q · filed 2020-11-09 | $83.06M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $82.00K 10-Q · filed 2020-08-10 | $73.15M derived: sum of 3 quarters · filed 2020-08-10 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 | $73.07M derived: sum of 2 quarters · filed 2020-03-16 | ||
| 2018-12-31 | $73.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $72.31M 10-K · filed 2020-03-16 | ||
| 2018-09-30 | -$764.00K 10-Q · filed 2019-11-12 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $28.70M 10-K · filed 2019-04-01 | ||
| 2017-09-30 | $28.70M 10-Q · filed 2018-12-03 |